Abstract
A 45-year-old hypertensive female with insulin-treated diabetes mellitus presented to our clinic with elevated urinary norepinephrine (NE) concentrations and a negative 131-metaiodoben-zylguanidine (MIBG) scintigraphy, errouneously limited to the abdomen, for evaluation of a pheochromocytoma (Pheo). Despite antihypertensive medications blood pressure remained highly variable and frequently elevated. Further biochemical testing, including a glucagon provocation test and a clonidine-suppression test, revealed autonomous NE secretion. In order to avoid repeat MIBG-scintigraphy, other non invasive imaging techniques were performed, including real time sonography (7.5 MHz) of the neck which revealed a tumor. Fine needle aspiration of this tumor tissue demonstrated cells compatible with Pheo. Histology and immunohisto-chemistry of the excised tumor confirmed the diagnosis of Pheo. After surgical removal of the tumor, urinary and plasma NE levels normalized. Without any medication the blood pressure of the patient was now only slightly hypertensive. Only half of the daily insulin dose was needed to maintain the patient euglycemic.
Similar content being viewed by others
References
Bauch H.J., Kelsch U., Hauss W.H. Einfache, schnelle, selektive und quantitative Bestimmung von Adrenalin und Noradrenalin im Plasma durch Kombination von Flussigkeitsextraktion, HPLC-Trennung und elektrochemischer Detektion. J. Clin. Chem. Clin. Biochem. 24:651, 1986.
Beard CM., Sheps S.G., Kurland L.T., Carney J.A., Lie J.T. Occurance of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. Mayo Clin. Proc. 58: 802, 1983.
Benowitz N.L. Pheochromocytoma. Adv. Intern. Med. 58:195, 1990.
Bravo E.L., Gifford R.W. Pheochromocytoma: Diagnosis, localization and management. N. Engl. J. Med. 377:1298, 1984.
Bravo E.L., Tarazi R.C., Fouad F.M., Vidt D.G., Gifford R.W. Clonidine-suppression test: A useful aid in the diagnosis of pheochromocytoma. N. Engl. J. Med. 305:623, 1981.
Chatal J.F., Charbonnel B. Comparison of iodobenzylguanidine imaging with computed tomography in locating pheochromocytoma. J. Clin. Endocrinol. Metab. 67:769, 1985.
Cone T.E. Recurrent pheochromocytoma: Report of a case in a previously treated child. Pediatrics 79:44, 1958.
Duncan M.W., Compton P., Lazarus L, Smythe G.A. Measurement of norepinephrine and 3,4-dihydrox-yphenylglykol in urine and plasma for the diagnosis of pheochromocytoma. N. Engl. J. Med. 379:136, 1988.
Sheps S.G., Jiang N.S., Klee G.G. Diagnostic evaluation of pheochromocytoma. Endocrinol. Metab. Clin. North. Am. 77:397, 1988.
Stimpel M., Wambach G. Diagnosis of pheochromocytoma. Dtsch. Med. Wschr. 112: 1422, 1987.
St John Sutton M.G., Sheps S.G., Lie L.J. Prevalence of clinically unsuspected pheochromocytoma. Mayo Clin. Proc. 56:354, 1981.
Taylor H.C., Mayes D., Anton A.H. Clonidine suppression test for pheochromocytoma: Examples of misleading results. J. Clin. Endocrinol. Metab. 63:238, 1986.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Becker, G., Jockenhövel, R., Bauer, R. et al. Cervical pheochromocytoma: a rare localization and a difficult diagnosis. J Endocrinol Invest 15, 767–770 (1992). https://doi.org/10.1007/BF03347649
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03347649